NCT03830918
- Conditions
- Advanced Malignant Solid Neoplasm, Bronchial Neoplasms, Carcinoma, Bronchogenic, +16 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Clinical trial condition
Small Cell Lung Carcinoma
Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.
820 public trials
196 recruiting studies
Small Cell Lung Carcinoma trial results
Active, Not Recruiting
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
NCT03228667
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +79 more
- Locations
-
- Alaska Clinical Research Center Anchorage, Alaska, United States
- Genesis Cancer Center Hot Springs, Arkansas, United States
- Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
- MemorialCare Health System Fountain Valley, California, United States
Active, Not Recruiting
A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer
NCT05353257
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-Stage Small Cell Lung Cancer, +8 more
- Locations
-
- OPN-Glendale Arcadia, California, United States
- OPN-Los Alamitos Los Alamitos, California, United States
- Southern California Permanente Group Los Angeles, California, United States
- Emad Ibrahim, MD, Inc Redlands, California, United States
Active, Not Recruiting
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
NCT03782207
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
- Locations
-
- Hospital Universitario Austral Buenos Aires, Argentina
- Lucen S.A. Buenos Aires, Argentina
- Consultorio Privado Korbenfeld CABA, Argentina
- Hospital Italiano de Buenos Aires Ciudad Autonoma Buenos Aires, Argentina
Active, Not Recruiting
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
NCT05740566
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Alaska Oncology and Hematology Anchorage, Alaska, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- University of California Los Angeles Santa Monica, California, United States
Active, Not Recruiting
Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer
NCT03728361
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +27 more
- Locations
-
- Ohio State University Comprehensive Cancer Center-COHORT 1 Columbus, Ohio, United States
- Ohio State University Comprehensive Cancer Center-COHORT 2 Columbus, Ohio, United States
Active, Not Recruiting
Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab
NCT06211036
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +9 more
- Locations
-
- Infirmary Cancer Center Mobile, Alabama, United States
- University of Southern California Los Angeles, California, United States
- Yale New Haven Hospital New Haven, Connecticut, United States
- University Cancer and Blood Center LLC Athens, Georgia, United States
Active, Not Recruiting
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
NCT03703297
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
- Locations
-
- Research Site Tucson, Arizona, United States
- Research Site Santa Rosa, California, United States
- Research Site New Haven, Connecticut, United States
- Research Site Fort Myers, Florida, United States
Active, Not Recruiting
Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)
NCT03319940
- Conditions
- Bites and Stings, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Yale New Haven Hospital New Haven, Connecticut, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Winship Cancer Institute Atlanta, Georgia, United States
Active, Not Recruiting
Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
NCT03672773
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
- Locations
-
- CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States
- St. Joseph Heritage Healthcare Fullerton, California, United States
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Orlando Health, Inc. d/b/a Orlando Health UF Health Center Orlando, Florida, United States